User profiles for A. Gordon

Andrew M. Gordon

- Verified email at tc.columbia.edu - Cited by 17431

Lawrence A. Gordon

- Verified email at umd.edu - Cited by 15985

Ascelin Gordon

- Verified email at rmit.edu.au - Cited by 6956

Regulation of contraction in striated muscle

AM Gordon, E Homsher, M Regnier - Physiological reviews, 2000 - journals.physiology.org
Ca 2+ regulation of contraction in vertebrate striated muscle is exerted primarily through
effects on the thin filament, which regulate strong cross-bridge binding to actin. Structural and …

Early, accurate diagnosis and early intervention in cerebral palsy: advances in diagnosis and treatment

…, L Fetters, S Fiori, H Forssberg, AM Gordon… - JAMA …, 2017 - jamanetwork.com
Importance Cerebral palsy describes the most common physical disability in childhood and
occurs in 1 in 500 live births. Historically, the diagnosis has been made between age 12 and …

Is my species distribution model fit for purpose? Matching data and models to applications

…, JJ Lahoz‐Monfort, J Elith, A Gordon… - Global ecology and …, 2015 - Wiley Online Library
Species distribution models ( SDM s) are used to inform a range of ecological, biogeographical
and conservation applications. However, users often underestimate the strong links …

Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan

AN Gordon, JT Fleagle, D Guthrie, DE Parkin… - Journal of clinical …, 2001 - ascopubs.org
PURPOSE: To compare the efficacy and safety of pegylated liposomal doxorubicin (PLD) and
topotecan in patients with epithelial ovarian carcinoma that recurred after or didn’t respond …

Randomized phase III trial of gemcitabine compared with pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer

…, T Goss, MG Teneriello, AN Gordon… - Journal of Clinical …, 2007 - ascopubs.org
Purpose Ovarian cancer (OC) patients experiencing progressive disease (PD) within 6
months of platinum-based therapy in the primary setting are considered platinum resistant (Pt-R). …

Phase II study of liposomal doxorubicin in platinum-and paclitaxel-refractory epithelial ovarian cancer

AN Gordon, CO Granai, PG Rose… - Journal of Clinical …, 2000 - ascopubs.org
PURPOSE: Stealth liposomal doxorubicin (Alzal Corp, Palo Alto, CA) has a slower clearance
rate than free doxorubicin, resulting in sustained serum levels. Liposomal encapsulation …

The economics of information security investment

LA Gordon, MP Loeb - ACM Transactions on Information and System …, 2002 - dl.acm.org
This article presents an economic model that determines the optimal amount to invest to
protect a given set of information. The model takes into account the vulnerability of the …

Long-term survival advantage for women treated with pegylated liposomal doxorubicin compared with topotecan in a phase 3 randomized study of recurrent and …

AN Gordon, M Tonda, S Sun, W Rackoff - Gynecologic oncology, 2004 - Elsevier
OBJECTIVE: Provide long-term follow-up data for women treated in a randomized multicenter
study of pegylated liposomal doxorubicin compared with topotecan. METHODS: Patients …

Observation of Top Quark Production in Collisions with the Collider Detector at Fermilab

…, D Glenzinski, M Gold, J Gonzalez, A Gordon… - Physical review …, 1995 - APS
We establish the existence of the top quark using a 67 pb− 1 data sample of pp collisions at
s= 1.8 TeV collected with the Collider Detector at Fermilab (CDF). Employing techniques …

[HTML][HTML] Landscape of transcription in human cells

…, MJ Fullwood, H Gao, D Gonzalez, A Gordon… - Nature, 2012 - nature.com
Eukaryotic cells make many types of primary and processed RNAs that are found either in
specific subcellular compartments or throughout the cells. A complete catalogue of these …